AI assistant
Sending…
Larimar Therapeutics, Inc. — Director's Dealing 2021
Jul 2, 2021
33359_dirs_2021-07-02_11309712-606e-4f1f-9ab7-d133f1158e57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Larimar Therapeutics, Inc. (LRMR)
CIK: 0001374690
Period of Report: 2021-06-30
Reporting Person: Hamilton Thomas Edward (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-30 | Common Stock | P | 56710 | $8.75 | Acquired | 190130 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 159433 | Indirect |
More from Larimar Therapeutics, Inc.
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2